Save ₹62200
Masimo RAD 67 Pulse Co-oximeter with 1000 Test
Specification :
| Product name | Rad-67™ Pulse CO-Oximeter® |
| Brand | Rad-67™ |
| Model | Rad-67™ Pulse CO-Oximeter® |
| Application | Hospitals |
Masimo RAD 67 Pulse Co-oximeter with 1000 Test : Specifications
₹210,000.00 Original price was: ₹210,000.00.₹147,800.00Current price is: ₹147,800.00.
Category: Medical Equipments
Description
Masimo RAD 67 Pulse Co-oximeter with 1000 Test : Product description
Rad-67’s ability to provide portable spot-check monitoring measurements of both oxygen saturation and noninvasive hemoglobin makes it a single-device solution in multiple clinical and non-clinical settings, such as emergency rooms, pre-/post-surgery settings, and physicians’ offices.
When used with the rainbow® DCI®-mini sensor, Rad-67 provides spot-check monitoring with Next Generation SpHb technology. This technology significantly advances the forefront of noninvasive portable hemoglobin spot-check monitoring.
Key features :
HD Display
- Bright LCD, color display
- Automatic low power mode to conserve power
Auto-Brightness
- Ambient light sensor automatically adjusts screen brightness to optimize visibility
Rechargeable Battery
- Li-ion Battery
- Up to 6 hours battery life2
- 6 hours charging time
Be the first to review “Masimo RAD 67 Pulse Co-oximeter with 1000 Test” Cancel reply
Related products
-
+ wishlist+ compare
BPL 9108D 12 Channel ECG Machine 7 inch High Resolution Touch Screen Color LCD
₹120,000.00Original price was: ₹120,000.00.₹98,700.00Current price is: ₹98,700.00.Add to cart -
+ wishlist+ compare
RMS Vesta 301i Channel ECG Machine
₹42,000.00Original price was: ₹42,000.00.₹31,750.00Current price is: ₹31,750.00.Add to cart -
+ wishlist+ compare
Contec 12000 G Digital 12 Channel ECG Machine
₹95,000.00Original price was: ₹95,000.00.₹49,300.00Current price is: ₹49,300.00.Add to cart -
+ wishlist+ compare
Multipara 3 Monitor
₹18,000.00Original price was: ₹18,000.00.₹12,800.00Current price is: ₹12,800.00.Add to cart







Reviews
There are no reviews yet.